According to Yogesh Radke, long-term retail investor can continue to hold on GSK pharma in his portfolio. Or if he wants to exit, it is better to exit onscreen rather than tendering into the offer.
first published: Dec 17, 2013 01:20 pm
A collection of the most-viewed Moneycontrol videos.
